{'fraction_non_alphanumeric': 0.023668639053254437, 'fraction_numerical': 0.0, 'mean_word_length': 6.154929577464789, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Intra‐renal Administration of VEGF: A Potential Therapeutic Approach for Renovascular Disease

Vascular endothelial growth factor (VEGF) promotes microvascular (MV) proliferation and repair. We have shown that a pre‐emptive intra‐renal administration of VEGF preserves the function of the stenotic kidney by protecting the renal microcirculation. This study was designed to extend those observations and determine whether intra‐renal administration of VEGF can halt the progression and reverse renal injury.